A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

Versant Ventures continues to invest in the increasingly competitive obesity space, this time launching Helicore with $65 ...

Investigating the interplay of genetics, brain maturation, and mental health, this study reveals insights into adolescent ...

Obesity is typically assessed by measuring someone's body mass index, but now researchers are calling for a more nuanced ...

Instead of using the controversial body mass index, or BMI, to assess weight, an international group of scientists proposes ...

Jan. 27, 2025 — A study shows that patients with obesity and fatty liver-related cirrhosis who had bariatric (weight-loss) surgery significantly lowered their future risk of developing serious ...

A more comprehensive multiethnic genetic risk score strongly predicted new cases of type 2 diabetes, including for people ...

Obesity can put strain on the heart, resulting in an increased risk of conditions such as atrial fibrillation, or irregular ...

The author of a new guidebook on GLP-1s and other experts share their tips for how clinicians can optimize patient success ...

Gut microbiota plays a critical role in childhood obesity by influencing energy metabolism, inflammation, and appetite ...

It raises questions about the different impacts of acquired and genetic obesity on cancer risk, the role of aging in these effects, and the potential vicious cycle of deteriorating obesity ...

Glucagon-like peptide 1 receptor agonists (GLP1RA)—medications for type 2 diabetes and obesity that have recently been making headlines due to a rise in popularity as weight loss agents—have been ...